- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00625027
The Effect of Telehealth Ontario on Non-urgent Emergency Department Use at The Hospital for Sick Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Some studies have shown that certain telephone nursing advice lines are effective in reducing non-urgent emergency department use. However, to my knowledge, no study has investigated the efficacy of Telehealth Ontario in particular. There are important differences between Telehealth Ontario and other phone lines that have been evaluated, in terms of the method in which calls are handled, the diversity of the population served, and the place of the phone-in line within the health care system. These studies, the results of which cannot be extrapolated directly to Telehealth Ontario, should not replace the direct study of the impact and utility of Telehealth Ontario.
Currently Telehealth Ontario receives over 3000 calls daily from residents of Ontario who are concerned about their health. These callers rely on the advise of Telehealth nurses to direct the care they seek out for themselves and for their families. The provincial government also relies on Telehealth Ontario - to provide a useful service within the health care system, relieving the pressure on over-crowded emergency departments by directing patients with non-urgent medical complaints to more appropriate avenues of treatment. This will be the first study to examine the impact of Telehealth Ontario. Although only a small aspect of Telehealth's impact will be examined - the impact on non-urgent emergency department use at Sick Kids - it is an important first step. The results of this study may serve to guide modifications to Telehealth that will make it more accessible to specific groups within the community, more reliable in the advice it provides, and more effective in delivering its message to callers.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
All children presenting to the ED between 0600 and 2400 during the study period
Exclusion Criteria:
- Children arriving without an adult, as consent could not be obtained.
- Children with whose parents communication was not possible in English, as it was not possible to provide translation services for this study.
- Children arriving by direct transfer from another hospital.
- Children arriving by ambulance summoned by someone other than the parent or guardian.
- Children arriving at the ED for a pre-arranged visit/appointment.
- Children requiring immediate resuscitation.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Children presenting to the Emergency Department under the care of a parent or guardian, between 0600 and 2400 during the study period.
|
After obtaining consent the survey will be completed.
After a staff physician has assessed the patient, the chart will be consulted to retrieve the triage notes, diagnosis, treatment, and discharge recommendations.
The physician will be asked to comment on the 'urgency' of the complaint and whether the patient would have been treated equally well at a walk-in clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The triage categories among patients who did or did not have contact with a health care professional prior to arrival in the ED.
Time Frame: At time of visit to the ED
|
At time of visit to the ED
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The demographic and other details of patients arriving with urgent compared to non- urgent complaints.
Time Frame: At time of visit to the ED
|
At time of visit to the ED
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Dennis Scolnik, MB ChB, The Hospital for Sick Children
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000004841
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergency Department Visit
-
University of Wisconsin, MadisonRecruitingEmergency Department VisitUnited States
-
University of FloridaNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruitingEmergency Department Visit | Odontalgia
-
healthEworks LLCNational Institutes of Health (NIH)UnknownCompliance | Emergency Department Aftercare | Emergency Department UtilizationUnited States
-
University of Southern CaliforniaUniversity of California, Los Angeles; National Institute on Aging (NIA); University... and other collaboratorsWithdrawnEmergency DepartmentUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingHospitalization | Emergency DepartmentFrance
-
Centre Hospitalier de Saint-DenisRecruiting
-
Albany Medical CollegeCompletedNon-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room VisitUnited States
-
Brigham and Women's HospitalRecruiting
-
Wesley Medical CenterCardinal HealthTerminatedEmergency Department | Medication ReconciliationUnited States
-
Baylor Research InstituteBaylor University; JPS Health NetworkUnknownEmergency Department Overcrowding
Clinical Trials on Survey and Chart Review
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaHIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 PositiveMexico, Argentina, Brazil
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineRecruitingSystemic Lupus ErythematosusUnited Arab Emirates
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownSurvey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid PrescriptionsPain | Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingGenetic Mutation | MEN1United States
-
AmgenCompletedThrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura
-
Thomas Jefferson UniversityCompletedMalignant Solid NeoplasmUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Completed
-
Vanderbilt UniversityNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Hormone Receptor-Negative Breast CarcinomaUnited States